title: The impact of overactive bladder on health-related quality of life, sexual life and psychological health in Korea.
abstract: OBJECTIVE
  We aimed to estimate the prevalence of overactive bladder (OAB) in Korea, to assess the variation in prevalence by sex and age, and to measure the impact of OAB on quality of life.
  
  
  METHODS
  A population-based, cross-sectional telephone survey was conducted between April and June 2010 with a questionnaire regarding the prevalence of OAB, demographics, and the impact of OAB on quality of life. A geographically stratified random sample of men and women aged ≥30 years was selected.
  
  
  RESULTS
  The overall prevalence of OAB was 22.9% (male, 19%; female, 26.8%). Of a total of 458 participants with OAB, 37.6% and 19.9% reported moderate or severe impact on their daily life and sexual life (5.6% and 3.5%, respectively, in participants without OAB). Anxiety and depression were reported by 22.7% and 39.3% of participants with OAB, respectively (9.7% and 22.8%, respectively, in participants without OAB). Only 19.7% of participants with OAB had consulted a doctor for their voiding symptoms, but 50.7% of respondents with OAB were willing to visit a hospital for the management of their OAB symptoms.
  
  
  CONCLUSIONS
  This study confirmed that OAB symptoms are highly prevalent in Korea, and many sufferers appear to have actively sought medical help. OAB has severe effects on daily and sexual life as well as psychological health.
authors.affiliation: Department of Urology, Kyungpook National University School of Medicine, Daegu, Korea.
authors.forename: Eun Sang
authors.initials: ES
authors.lastname: Yoo
authors.forename: Bum Soo
authors.initials: BS
authors.lastname: Kim
authors.forename: Duk Yoon
authors.initials: DY
authors.lastname: Kim
authors.forename: Seung-June
authors.initials: SJ
authors.lastname: Oh
authors.forename: Joon Chul
authors.initials: JC
authors.lastname: Kim
references.citation: Int Urogynecol J Pelvic Floor Dysfunct. 2001;12(4):226-31
references.pmid: 11569649
references.citation: Urology. 1997 Dec;50(6A Suppl):4-14; discussion 15-7
references.pmid: 9426746
references.citation: BJU Int. 2004 Mar;93(4):528-31
references.pmid: 15008723
references.citation: Arch Esp Urol. 2005 Mar;58(2):131-8
references.pmid: 15847270
references.citation: Urology. 2006 Aug;68(2):318-23
references.pmid: 16904444
references.citation: BJU Int. 2001 Jun;87(9):760-6
references.pmid: 11412210
references.citation: J Clin Epidemiol. 1998 Aug;51(8):677-85
references.pmid: 9743316
references.citation: Urology. 2004 Oct;64(4):772-6
references.pmid: 15491718
references.citation: Eur Urol. 2005 Jun;47(6):824-37
references.pmid: 15925080
references.citation: Eur Urol. 2005 Mar;47(3):385-92; discussion 392
references.pmid: 15716205
references.citation: Eur Urol. 2006 Dec;50(6):1306-14; discussion 1314-5
references.pmid: 17049716
references.citation: World J Urol. 2003 May;20(6):327-36
references.pmid: 12811491
references.citation: Urology. 2003 Jan;61(1):37-49
references.pmid: 12559262
references.citation: Am J Manag Care. 2000 Jul;6(11 Suppl):S580-90
references.pmid: 11183901
references.citation: Eur Urol. 2003 Nov;44(5):588-94
references.pmid: 14572759
references.citation: Scand J Urol Nephrol Suppl. 1988;114:5-19
references.pmid: 3201169
references.citation: J Public Health (Oxf). 2005 Sep;27(3):281-91
references.pmid: 15870099
references.citation: Arch Androl. 2006 May-Jun;52(3):155-62
references.pmid: 16574595
references.citation: World J Urol. 2011 Apr;29(2):185-90
references.pmid: 19898824
references.citation: J Clin Epidemiol. 1995 Mar;48(3):339-43
references.pmid: 7897455